AstraZeneca/MSD’s Koselugo Among 14 New Hopefuls At EMA

EU Filing Of Semumetinib Coincides With US Approval

 
• By Neena Brizmohun

New drugs from Eli Lilly, Pfizer, Janssen, GSK, Arvelle, BioCryst, Diurnal and Myovant are also among the latest products the European Medicines Agency is evaluating for potential pan-EU approval.

Concept of national healthcare system - EU - European Union
New applications to market drugs across the EU are being assessed • Source: Shutterstock

More from Europe

More from Geography